Fortrea Denmark ApS: Financial statements 2014
CVR: 35240446
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Fortrea Denmark ApS (CVR 35240446) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 23,337,358 and a net result of DKK 1,697,507. Equity in the 2014 report amounted to DKK 3,703,163. The solvency ratio was 46.1%.
- Gross Profit
- DKK 23,337,358
- Profit/Loss
- DKK 1,697,507
- Equity
- DKK 3,703,163
- Total Assets
- DKK 8,037,526
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Fortrea Denmark ApS has published its interim report for the period May 8, 2013 – December 31, 2013.
About Fortrea Denmark ApS
Fortrea Denmark ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Labcorp Clinical Development ApS and COVANCE DENMARK ApS. The management consists of Agnieszka Moskal Gallagher. The company is owned by Fortrea Development Ltd.. The company has 43 employees (2018). In 2025, the company reported a gross profit of DKK 29,191,545 and a net result of DKK 1,739,960 compared with DKK 688,702 the year before. Equity in the 2025 report amounted to DKK 10,187,341.